Martine F. Roussel, PhD is a member of two Crazy 8 teams--"Drugging MGYN" and "Small Molecule Degraders for Targeting Transcription Factor Drivers of Childhood Cancers."

Dr. Roussel is a pioneer in the field of molecular oncology and translation cancer research, having discovered some of the earliest recognized retroviral oncogenes and defined central elements in cell cycle regulation. Born and educated in France, with research experiences spanning the globe, Dr. Roussel carved an impressive path that has shattered glass ceilings and earned renowned honors. Elected to the American Academy of Arts and Sciences in 2011, National Academy of Science in 2019 and a Fellow of the AACR in 2021, Dr. Roussel continues her long-standing and illustrious career at St. Jude driving discovery, creating clinical impact, and inspiring the next generation of scientists. Dr. Roussel is a transformative force in the pediatric brain tumor community thanks not only to her robust research portfolio, but her commitment to mentorship and training.